Nike announced that David M. Denton will join the company as Executive Vice President and Chief Financial Officer, effective August 17, 2026. Denton comes to Nike from Pfizer Inc., where he served as Chief Financial Officer and Executive Vice President since May 2022. This appointment marks a return to the consumer sector for Denton, as his previous experience includes roles as CFO at Lowe's Companies, Inc. from 2018 to 2022, and two decades at CVS Health Corporation, including as Executive Vice President and CFO.
Denton will replace Matthew Friend, who will step down from the CFO role on August 17 but remain with Nike until September 4 to ensure a smooth transition. Friend is also expected to participate in the company's fourth-quarter fiscal 2026 earnings call on June 30. The transition is seen by Nike's President and CEO, Elliott Hill, as a natural moment for leadership change as the company moves towards sustained growth through its "Sport Offense" operating model.
While Denton's extensive finance and operating leadership experience across complex global public companies is highlighted, the market is scrutinizing the implications of his recent pharmaceutical background at Pfizer. However, his previous tenures at Lowe's and CVS Health demonstrate significant experience in consumer-facing industries, potentially mitigating concerns about his fit for Nike's consumer goods market. Denton will lead Nike's global finance organization, partnering with the CEO and senior leadership team to support disciplined execution, capital allocation, and long-term value creation.
